 Hi, how's everybody doing today? I'm Rich here on behalf of Rich TV Live. Your host with our very special guest, Bahid Shabibi, the Chief Growth Officer of Victory Square Technologies. How are you doing today, Bahid? Hi, Rich. Thanks for having me. I'm great. I hope everyone is well. I'm feeling great. I know that there's been a lot of news with Victory Square Technologies, so let's get right into it. Can you tell us a little bit about Victory Square Technologies and how you got involved? Absolutely. So, at Victory Square Technologies, we buy, build, and invest in tech giants of the future globally. So, the way that we got to this concept, we actually started it in the mid-90s. When we saw the internet was going to disrupt how people across, how people are having access to the information and connecting with each other. So we identified the opportunities in mid to late 90s and in connecting people and started dating websites back then in early ages. That was a great opportunity that we found was great, brought lots of traffic, positive cash flow, and when we got to that point, then we look for what's next as far as what can be the next destinations for the crowd and the customers that we already have so we can buy or build the next destination. Going back in the last 30 days, we've seen how tech disrupted our people's lives through internet and mobile and all these changes that is happening. And since three, four years ago, we started focusing on the next revolution, tech revolution, we call it the fourth industrial revolution, which we feel is around intelligence and data. It's around personalized medicines, AI, AR, VR, digital health, cybersecurity and start either investing or building companies that could be ready for it when the next wave comes. So now, again, COVID kind of expedited this process and we see many of these that maybe six, seven months ago were not as of a hot topic like telehealth, for example. Now it's a hot topic and expedited this revolution. So because we focused in this from three, four years ago, now we have our companies, our portfolio companies, to be ready with their product, with customers and having experience after two, three years serving those services and being ready for this. So right now, we're focusing on these portfolio companies, the 23 portfolio companies that we've been working with them, you know, since three, four years ago and we invested in the last two, three, four years. Now can you update us on Victory Square health and the progress with your 15 minute rapid tests for COVID-19? Absolutely. So again, through the same process that I described earlier, we identified an opportunity around diagnostic testing and health tech about like three years ago and we invested in the company called, we founded a company called Victory Square Health. Originally, we invested it in a project called Personal Biomakers Inc. It's a PBI and focusing also on identifying the opportunities in health tech. We were monitoring a company from Brazil for a passion and a half and we acquired the company called SafeTest from Brazil. This company has seven, eight different diagnostic tests. Two of the tests that they have is around COVID-19. Now we acquired this company earlier this year and when we acquired this company, our focus around all the diagnostic tests that they have, especially on COVID-19 because of what is happening around the world was on four different areas. One, getting the approvals from the government entities, you know, approvals that is needed for different jurisdictions to have a good relationship with the governments and get approval to make sure we are within the framework that each government is asking. At the same time, we're also trying to lock down different distributions and distributors in different jurisdictions around the world because that would have expedited the process for getting a greater reach on finding the customers and also working on the capacity of manufacturing capacity, especially around COVID-19 because as we see the demand is high and this demand is not going to come down anytime soon and to help the economy to go back to normal safely or people going back to school or families going back to the semi-normal, we wanted to make sure that we can contribute into that and also support our business. The fourth area that we've been focusing on is the full-service tech for around the healthcare around the health and having our health tech ready to go by Q1 2021. Now, through that, the two different tests that they have. One is the ELISA three-hour lab test and the other one is a 15-minutes rapid test antibody test. So the ELISA test, the approval process was quicker. We received the FDA permission under EUA Stage 1 to be able to sell and market within the United States. We received an ELISA for Brazil so we can sell the test in Brazil and we received EU which is the CE mark to be able to market and sell in Europe. Rapid test, the antibody rapid test, the approval process and submission process was longer because of the clinical evaluation and the numbers and different things that we needed to do about the technical perspective that we received the FDA permission under EUA Stage 1 to sell in the United States. We just received the EU mark and approval for European unions and our application is under review with Health Canada and in Mesa and Brazil that we're expecting to receive those approvals open reviewing our applications. So that's the latest we had, the EU approval that we got that opened a huge door for us simply because we were in conversation with many distributors and we couldn't simply send them and samples to them and signed the contract because we needed it to have those approvals. And team is working really hard on working with Health Canada and in Mesa to get those approvals as well. However, also the team is not pausing the conversation and contracts for distribution themselves because many of these contracts that it's on the jurisdictions that we don't have approval is there is a term that is often receiving approval, so there's pending to that. That was actually leading into my next question. So have you guys secured any sales and distribution contracts yet? So that's actually a very good question. So we have received a two million order with one of the largest PPE providers in Canada called TM Safety and are basically contract with them and the agreement with them is not only they're going to start selling our tests to their customers, but also they give Victory Square Health and Victory Square Technologies access to all their PPE items at the cost price so other distributors of ours, if they want the PPE, that can go through Victory Square Health and create another avenue for revenue for the company. That's depending on the health Canada approval. We also working with some associations in Canada, Canadian Gaming Associations will be finalized agreement with them that they oversee the casinos and the gaming in Canada. Also the Canadian police that we had an agreement with them right now, all that is depending to the health Canada approval. From Brazil, we had a few orders. You know, one of the orders is on the rapid test that we are waiting for and visa to give us that final approval to be able to stop producing it and passing it to the customers. Also in Europe, there are few distribution contract that has been finalized. Now, since we received the EU, we started producing the test and the samples will be shipped to them in next 14 days for basically for their approval. And then often that basically we're going to start shipping the actual orders. Also in the meantime, we finalize some agreements and distribution agreements with partners in Southeast Asia that, you know, the agreement that we have with them is in two folds. One is for them to distributing our test and the PPE items that we have. And the second part of it is they're also leading us and helping us to receive necessary approvals within these jurisdictions. That's incredible. You guys are doing so much work on an international level. It's it's impressive. And you just did a four million dollar private placement. What was the logic behind that? So the four million private placement that we announced, that was a very strategic move that we needed it to do. And there are a few reasons behind that. As as most of our shareholders know, we've had access to a ten million dollars convertible notes by our CEO, Shafiq Diamond Dajani in last four years. And we've been using that for the operation budgets and cost as well as investing in our portfolio companies or new opportunities. And we still have access to that ten million dollar convertible notes. But when we plan for the company, we don't only look at the next step, what we try to do. We try to see actually five or six steps ahead of us and see how we can pave the way for us to get there. One of the items that we feel we needed to do based on the private placement is diversifying our investors to welcoming institutes to to to come as an investors, some strategic investors that they've been very active and supportive of some larger projects in health care and health that not only in this round, but also later on when the company grows, if the company needs more funding for bigger projects and going after more acquisitions and all that, the people that we have as investors, we have a diversified investor base for us. Also, when we do that, we've never done a proper raise at DST, meaning the raise that we've done and then the shareholders that we had is from our CEO and investors around us. Now, doing this and doing it properly with an investment bank, it helps the Victoria Square to be showcased in different researchers with different analyst coverages that we need and bring more eyeballs on Victoria Square technology through other institutes that is happening. Also, the other plan that we have is uplifting and uplifting DST, which the raise was one of the key components that we needed to do on that one. Now, in order to bring this strategic investment investors, we needed to have the entry points was very important, how we can welcome these people into the investor base that we have, because we've really been very grateful for the investors that we already have with the support that they have, the communication they're reaching out, asking questions and supporting us in thick and thin in the past few years that we have. Now, we wanted to make sure the decision is something that everyone can benefit from that. And bringing this strategy and investors is going to support our future growth. When we look at some other successful companies that have done this and doing it more and more, such as Well Health, Cloud and Visa, like great companies with a great management team that are doing a great job right now, this is a similar path that also they took. And we needed to bring this investor base for our future growth. And having more cash for the companies always is beneficial for the investors and the company, because that makes us, that empowers us to not only find other opportunities to invest, but also it gives us more power in capturing the best opportunity at any given time. Now, it's really important for us to find companies that have very tight share structure. It's one of the key elements to our success as a community. We love tight float stocks. Victory Square Technologies has a very tight flow. Can you talk a little bit about the share structure and what the percentages are of insiders and institutions that have taken a position in Victory Square Technologies? Absolutely. So we have over 75 million outstanding shares today in market. And around 30% of that are being called by insiders and management team. The largest shareholder for the company as of today is the CEO of the company, Shifin Diamond. Nobody from the management team has exercised or sold any stock in past 12 months, I don't think even 24 months, because we all believe in the long the long term goal that we have and we're in it with our shareholders. So the management team has been in it and we believe in this in this project that we're working on right now. From the institution, I'm not really sure. And that was one of the key points that we wanted to do, the four million private placement that we announced to welcome some of the Institute to come in and support us, support our future growth as well. So as I mentioned, currently is I think is over 75 million outstanding shares in the market. Now, Victory Square Technologies has quite an impressive roster of experts. Who are your key members and what do they bring to the table? So I answer your questions in two different categories. One of the key element of success for us is our partnerships and with not only the 80 plus accelerator around the world that we have access to to find the right opportunity, but also some major companies in the market that give us access to opportunities and they can become our first customers or their customers become our first customers or they help us to identify the pains within the market and find the solution for it. The second part of it is the management team and our advisors. We have a very experienced advisory group around us that when we take over a company or when we invest in the company, we are not a passive investors. We identify the main needs that they have and we put an advisory team to get their based on advisors that we have and we have them to work directly with this company. So the two big elements that we have is one advisory team and the management team that they're working with the company's hands on. And the second part of it is our partnerships that, you know, enabled us to have access to the customers and also have access to the companies because if, you know, if you remember from from the first question that you have, the way that we look at things is we're creating this ecosystem. Either we usually go after finding a solution or product for existing customers that we have through our ecosystem or we go find, you know, a company that have extra users or customers for one of the products that we have. And that reach will help us to to find one or the other and help our portfolio companies and Victory Square and, you know, eventually our shareholders. If there was one thing that you would want shareholders to know about Victory Square Technologies, Inc. What would it be? So the biggest thing for the Victory Square Technology is we're not a company to to look at our next steps. We'll look at it at next five or six steps, right? So right now there is a hub market around COVID and we're trying to capitalize around the COVID. But even the Victory Square help by itself, that's not it. We're trying to have these customers to come in and creating that customer base when we're helping the community, when we are generating revenue for the company. But there are, you know, another seven or eight diagnostic tests and our, you know, telehealth and health tech, you know, is going to be launched, you know, hopefully by Q1 that then we have users for it. Now, that's only the Victory Square help. There are 22 other portfolio companies in AR, VR, gaming, cybersecurity, you know, that that benefits our shareholders. So the Victory Square right now, I feel we are at, you know, earliest stages of a big growth from the portfolio perspective, from the revenue perspective, from the value perspective. And the management team is in it, you know, and we all have a skin in the game, you know, trying to be hands on as much as we can with our portfolio companies and to pay back the support and the trust that our shareholders are giving us. Now, it's very, very important for our investors to be able to get in contact with the company, they have a question, if they want to learn more, how do they get in contact with you, Vahid? So I personally have been trying to be in touch with our shareholders myself when they reach out, because I think that's the biggest thing. Sometimes when the shareholders are seeing it, they have the public trader company, let me take one step back, public trader company have advantage and some disadvantages. One disadvantage from my perspective is the communications are limited because we need to follow the procedures and protocols by different government bodies, which trying to make this game fair for everyone. Because of that, obviously, we can talk about some of the things that, you know, it's happening or hasn't been finalized yet. So that makes it a bit hard. But I personally has been trying to be accessible to our shareholders as much as I can, simply because, number one, they deserve to have this conversation, provide feedback. Sometimes the feedback that we're getting are very great feedback that it helps the community and helps the rest of the sharehold and helps the company. However, not only the management is interested to talk to shareholders, but we have an IR that is always reachable. You know, obviously, sometimes one to one is hard and takes time based on the number of the shareholders. We have an mailing list that we always update the shareholders based on the latest releases or updates around the corporate updates. They can join our mailing list through our website, victorysquare.com. And we also have, you know, almost all the social media channels. There is something almost because every day the new social media channel opens up. But like on Facebook, on Twitter, on LinkedIn, we have that. They can follow us through that. Management team, myself, Shafiqeen, Diamond, Tejani, our board members, they all are on LinkedIn, will be more than happy to connect with them through that. Again, we feel the personal touch is the biggest thing because that has been our recipe of success, to be accessible to our shareholders, to our companies, to the people around us, to make sure that we hear them. And obviously, there's going to be some noise that we need to filter out. But getting more ideas and getting more solutions, always more helpful for people to make the best decision for the company. And as I said, focusing in five, six, and 10 steps ahead and come, you know, go back today to see what is needed to be done, rather than focusing on one step or two steps. Super excited to have this interview with you today. And I'm really excited about what's coming next. I've been watching you guys' news and it seems as though it just keeps getting better and better. And I love telemedicine and you guys are in telemedicine. I love gaming. You guys are in gaming. I love virtual reality. You guys are in virtual reality. So I love the businesses that you guys are involved with. I really like Victory Square Technologies. I like the share structure, like the management team. I like the direction you guys are going in. And when I went through the website, one of the things that caught my attention is your revenue growth potential is spectacular. So I really agree with you when you say that you're in the early stages. So congratulations on your success. I believe you're probably still just in the first inning. So hopefully we can have you come back as you guys continue to evolve and have big breaking news. I'd love to have you come back on our show so we can discuss it. Thank you for joining us today. And I appreciate it. The Chief Growth Officer of Victory Square Technologies, Bahid Shabibi, thank you for joining us today. Thanks for giving us this time. And again, you said it well. It's just for us is right now COVID expedited at this revolution that we've been expecting to come in next 12 to 18 months. But, you know, we're very grateful that we made this space and foundation ready to be ready for this. So, you know, I appreciate you giving us time to speak with our investors and potential investors and the world. And we look forward to chatting with you more. Absolutely, guys. Put Victory Square Technologies on your radar, put on your watch list. Thank you, Bahid. Have yourself a nice day and we'll talk to you soon. Thank you, sir. Thank you guys for watching. We'll talk to you soon.